Quick Takeaways
- Clare Kahn has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $15,794.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Clare Kahn
- Location
- Cambridge, MA
- Summary
- The estimated net worth of Clare Kahn is at least $15,794 dollars as of 07 Apr 2026. Clare Kahn is the Director of Solid Biosciences Inc. and owns shares of Solid Biosciences Inc. (SLDB) stock worth about $15.8K.
- Signature
- /s/ Jonathan Allan, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Clare Kahn and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Solid Biosciences Inc. ($15,794).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Clare Kahn
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SLDB | Solid Biosciences Inc. | Director | $15,794 | 12 Jun 2025 | ||
| STOK | Stoke Therapeutics, Inc. | Director | 03 Apr 2026 |
Insider Transactions Reported by Clare Kahn:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.